Tom Davison Joins Domain Surgical in Advisory Role

Domain Surgical, a leading developer of advanced thermal surgical technology, today announced that Thomas W. Davison, Ph.D., has joined the company in a business and technical advisory role.
 
SALT LAKE CITY - April 26, 2013 - PRLog -- Domain Surgical, a leading developer of advanced thermal surgical technology, today announced that Thomas W. Davison, Ph.D., has joined the company in a business and technical advisory role.

Dr. Davison has over 40 years of experience in the medical device industry. Davison was founder and CEO of UltraCision, which was acquired by Ethicon Endosurgery (Johnson & Johnson) and is now the $1 billion HarmonicĀ® product line. Davison is currently Chairman and CEO of HistoSonics, a developer of histotripsy therapeutic ultrasound technology based in Ann Arbor, Michigan.

"Domain Surgical is honored to have Dr. Davison join our advisory board," said David McNally, President and CEO of Domain Surgical. "His success with UltraCision is legendary. Now Ethicon's billion-dollar Harmonic product line, it represents one of the most important developments in advanced energy surgical devices in the past 80 years. With Tom's help, we aim to emulate that success."

Domain Surgical has commercialized a new system for precise cutting and coagulation of soft tissue, the FMwand Ferromagnetic Surgical System. The FMwand uses pure thermal energy to cut and coagulate tissue, without passing electrical current through the patient. It has been shown to be safe and effective for dissecting around delicate tissues and structures such as nerves and blood vessels. The FMwand minimizes collateral tissue damage, causing as little as 1/10th the depth of thermal damage compared to standard electrocautery in some tissue types, preserving more viable, healthy tissue beyond the incisional plane.

"Domain Surgical has developed a very impressive energy platform and the management team has done an exceptional job of positioning the product line for use in clinical applications where it has significant clinical and economic advantages. Additionally, Domain Surgical is postured for sustained growth with its new product and clinical application pipeline." said Dr. Davison.

Dr. Davison is the Chairman and CEO of HistoSonics, LLC which he founded in late 2009 with management and scientists at the University of Michigan to commercialize the U of M's non-invasive ultrasound surgical ablation technology, Histotripsy. Dr. Davison is also President of MedTech Innovations, LLC which he founded in January, 2007 to help scientists and entrepreneurs bridge the gap between medical technology and business. Dr. Davison was Chairman of Board of Directors of Chart Medical (2007 - 2011), which he co-founded in 2007 to reintroduce Chymopapain injection for treatment of lumbar disc herniation. Prior to founding MedTech Innovations, Dr. Davison was President and CEO of Sontra Medical Corporation (NASDAQ SC: SONT). Dr. Davison led the Company's transition from an early stage R&D company to develop the first transdermal glucose monitor for critical care. Sontra merged with Echo Therapeutics in late 2006. Prior to joining Sontra, Dr. Davison was the Chief Executive Officer of Endius, Inc., which he co-founded in 1997. At Endius, Dr. Davison invented and commercialized the first endoscopic spine fusion technology and surgical procedure. Endius was acquired by Zimmer Holdings in June 2007. Prior to Endius, Dr. Davison was the co-founder and President of UltraCision, the market leader in advanced directed energy surgical systems. While at UltraCision, he led a team of engineers to develop the Harmonic ScalpelĀ®. UltraCision and the Harmonic Scalpel were sold to Ethicon Endosurgery, a Johnson & Johnson company in late 1995. Today, the Harmonic Scalpel sales exceed $1 billion worldwide.

About Domain Surgical, Inc.
Domain Surgical is a privately held company based in Salt Lake City, Utah. The company has commercialized a product line of capital equipment and single-patient-use disposables designed to address the known shortcomings of leading energy-based surgical equipment. Domain Surgical's patented technology produces surface-only tissue effects without passing electrical energy through the patient, and is designed with simple user interface for ease of use by the surgical staff. For more information, please visit www.domainsurgical.com.
End
Source: » Follow
Email:***@domainsurgical.com Email Verified
Tags:Advisor, Medical, Board
Industry:Medical
Location:Salt Lake City - Utah - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Domain Surgical, Inc. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share